Image pharmaphorum Editor News Hepatitis drug wins award for cure rate and efficacy Hepatitis C drug Ganovo won a top clinical research award due to its successful performance in a phase 3 trial. News Sanofi stockpiles drugs in case of no-deal Brexit Fears of border delays and complications in a post-Brexit UK have led to the French pharmaceutical company increasing its contingency stockpiles by four weeks to enable a 14-week supply of News Roche’s MS drug Ocrevus earns blockbuster status a year afte... Roche’s multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has claimed blockbuster status just one year after it was launched. News FDA refuses to approve Insys opioid painkiller The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety. Load more results
News Hepatitis drug wins award for cure rate and efficacy Hepatitis C drug Ganovo won a top clinical research award due to its successful performance in a phase 3 trial.
News Sanofi stockpiles drugs in case of no-deal Brexit Fears of border delays and complications in a post-Brexit UK have led to the French pharmaceutical company increasing its contingency stockpiles by four weeks to enable a 14-week supply of
News Roche’s MS drug Ocrevus earns blockbuster status a year afte... Roche’s multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has claimed blockbuster status just one year after it was launched.
News FDA refuses to approve Insys opioid painkiller The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.